Perioperative management of diabetes insipidus in children.
Managing children with diabetes insipidus (DI) in the perioperative period is complicated and frequently associated with electrolyte imbalance compounded by over- or underhydration. In this study the authors developed and prospectively evaluated a multidisciplinary approach to the perioperative management of DI with a comparison to 19 historical control children. Eighteen children either with preoperative DI or undergoing neurosurgical operations associated with a high risk for developing postoperative DI were identified and managed using a standardized protocol. In all patients in whom DI occurred during or after surgery, a continuous intravenous infusion of aqueous vasopressin was initiated and titrated until antidiuresis was established. Intravenous fluids were given as normal saline and restricted to two thirds of the estimated maintenance rate plus amounts necessary to replace blood losses and maintain hemodynamic stability. In all children managed in this fashion, perioperative serum sodium concentrations were generally maintained between 130 and 150 mEq/L, and no adverse consequences of this therapy developed. In the 24-hour period evaluated, the mean change in serum sodium concentrations between the historical controls was 17.6 +/- 9.2 mEq/L versus 8.36 +/- 6.43 mEq/L in those children managed by the protocol. Hyponatremia occurred less frequently in the children managed with this protocol compared with historical controls.
Wise-Faberowski
Lisa
L
Children's Hospital Boston and Harvard Medical School, Boston, Massachusetts, USA. Faber007@mc.duke.edu
Soriano
Sulpicio G
SG
Ferrari
Lynne
L
McManus
Michael L
ML
Wolfsdorf
Joseph I
JI
Majzoub
Joseph
J
Scott
R Michael
RM
Truog
Robert
R
Rockoff
Mark A
MA
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000097:blood / Q000209:etiology; D007038:Hypotonic Solutions / Q000008:administration & dosage / Q000009:adverse effects; D007262:Infusions, Intravenous; D008297:Male; D019635:Neurosurgical Procedures / Q000009:adverse effects; D019990:Perioperative Care / Q000379:methods; D011183:Postoperative Complications / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D011446:Prospective Studies; D012076:Renal Agents / Q000627:therapeutic use; D012640:Seizures / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D012964:Sodium / Q000097:blood; D014667:Vasopressins / Q000627:therapeutic use; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
D007038:Hypotonic Solutions; D012076:Renal Agents; D014667:Vasopressins; D012964:Sodium; D003894:Deamino Arginine Vasopressin